The anti-apoptotic protein survivin can improve the prognostication of meningioma patients
Fig 3
Grouped scatter plot of labeling indices in recurrent vs. non-recurrent meningiomas.
Survivin LIs were significantly higher in recurrent meningiomas compared to non-recurrent meningiomas, while no difference was found in MIB-1 LI.